Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹22.82
Market cap: ₹126.0 Cr
Revenue (annual): ₹270.2 Cr
Net profit (annual): ₹1.42 Cr
P/E (TTM): 52.0×Sector 50.4×
Promoter holding: 65.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Financial Results 1 Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

6 Aug 2026 16:17 IST NSE

Earnings Call

Balaxi Pharmaceuticals Investor Presentation: Key Takeaways

Balaxi reported 14.1% YoY revenue growth in Q1 FY27, driven by market diversification and its first proprietary manufacturing facility. Strategy emphasizes backward integration in Latin America and Africa.

Open call summary → Read the filing ↗